|
Re: New Apabetalone Fabry Disease Publication
|
9
|
Resverlogix Corp.
|
Apr 27, 2022 09:57PM
|
|
Re: NEO Compensation
|
3
|
Resverlogix Corp.
|
May 22, 2021 02:37PM
|
|
Re: NEO Compensation
|
3
|
Resverlogix Corp.
|
May 22, 2021 02:42PM
|
|
Re: NAFLD is going to get much worse
|
2
|
Resverlogix Corp.
|
Jun 25, 2020 12:40PM
|
|
Re: More News Coverage on Global
|
6
|
Resverlogix Corp.
|
Feb 03, 2022 04:03PM
|
|
Re: Momentum Players and Agoracom.com’s Rules
|
4
|
Resverlogix Corp.
|
Dec 21, 2021 12:10PM
|
|
Re: Missed Event
|
3
|
Resverlogix Corp.
|
Aug 23, 2021 02:04PM
|
|
Re: Missed CEO replacement opportunity: Dr. David Kideckel
|
5
|
Resverlogix Corp.
|
Aug 23, 2021 04:53PM
|
|
Re: Metablock
|
3
|
Resverlogix Corp.
|
Dec 06, 2021 01:13PM
|
|
Re: Metablock
|
|
Resverlogix Corp.
|
Dec 06, 2021 06:42PM
|
|
Re: Merry Christmas/Happy Holidays
|
5
|
Resverlogix Corp.
|
Dec 25, 2021 12:06AM
|
|
Re: MERCK….
|
2
|
Resverlogix Corp.
|
Oct 05, 2021 10:59PM
|
|
Re: Merck’s pill
|
|
Resverlogix Corp.
|
Oct 07, 2021 07:12PM
|
|
Re: Merck’s pill
|
3
|
Resverlogix Corp.
|
Oct 07, 2021 02:48PM
|
|
Re: Merck's profit on Molnupiravir.
|
1
|
Resverlogix Corp.
|
Oct 08, 2021 11:59AM
|
|
Re: MD&A
|
1
|
Resverlogix Corp.
|
Sep 14, 2020 03:39PM
|
|
Re: Long term risks associated with covid
|
2
|
Resverlogix Corp.
|
Jan 05, 2022 10:18PM
|
|
Re: Long Covid thought to affect half of Covid cases
|
2
|
Resverlogix Corp.
|
Jun 24, 2021 03:33PM
|
|
Re: Long Covid thought to affect half of Covid cases
|
4
|
Resverlogix Corp.
|
Jun 24, 2021 04:58PM
|
|
Re: Long Covid thought to affect half of Covid cases
|
2
|
Resverlogix Corp.
|
Jun 24, 2021 03:25PM
|
